高级检索
当前位置: 首页 > 详情页

A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

| 认领 | |

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究参与人:
研究单位: [1]Bristol-Myers Squibb [2]Anhui Provincial Hospital,Hefei,Anhui,China,230071 [3]Local Institution - 0013,Wuhu,Anhui,China,241001 [4]Peking University International Hospital,Beijing,Beijing,China,102206 [5]Chongqing General Hospital,Chongqing,Chongqing,China,400014 [6]Zhongshan Hospital Affiliated to Xiamen University,Xiamen,Fujian,China,361004 [7]Local Institution - 0020,Guangzhou,Guangdong,China,510080 [8]Local Institution - 0036,Guangzhou,Guangdong,China,510180 [9]Local Institution - 0028,Guangzhou,Guangdong,China,510280 [10]Local Institution - 0019,Guangzhou,Guangdong,China,510515 [11]Local Institution - 0008,Guangzhou,Guangdong,China,510655 [12]Local Institution - 0004,Zhanjiang,Guangdong,China,524004 [13]Affiliated Hospital of Guilin Medical University,Guilin,Guangxi,China,541001 [14]Local Institution - 0023,Nanning,Guangxi,China,530021 [15]Local Institution - 0007,Shijiazhuang,Hebei,China,050000 [16]Local Institution - 0006,Shijiazhuang,Hebei,China,050011 [17]Union Hospital Tongji Medical College Huazhong University of Science and Technology,Wuhan,Hubei,China,430022 [18]Tongji Hospital Tongji Medical,Science & Technology,Wuhan,Hubei,China,430030 [19]Renmin Hospital of Wuhan University,Wuhan,HUB,China,430060 [20]Local Institution - 0027,Changsha,Hunan,China,410008 [21]The Third Xiangya Hospital of Central South University,Changsha,Hunan,China,410013 [22]Local Institution - 0061,Changzhou,Jiangsu,China,0 [23]Local Institution - 0046,Changzhou,Jiangsu,China,213003 [24]Local Institution - 0024,Nanjing,Jiangsu,China,210000 [25]Local Institution - 0045,Nanjing,Jiangsu,China,210029 [26]The Second Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China,215004 [27]Local Institution - 0009,Suzhou,Jiangsu,China,215006 [28]Wuxi People's Hospital,Wuxi,Jiangsu,China,214023 [29]Affiliated Hospital of Jiangsu University,Zhenjiang,Jiangsu,China,212000 [30]Shengjing Hospital of China Medical University,Shenyang,Liaoning,China,110004 [31]Xijing Hospital,Xi'an,Shaanxi,China,710032 [32]Tangdu Hospital of Fourth Military Medical University of Chinese People's Liberation Army,Xi'an,Shaanxi,China,710038 [33]Local Institution - 0039,Jinan,Shandong,China,250014 [34]Ruijin Hospital Shanghai Jiaotong University School of Medicine,Shanghai,Shanghai,China,200025 [35]Local Institution - 0041,Shanghai,Shanghai,China,200032 [36]Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai,Shanghai,China,200092 [37]Local Institution - 0015,Taiyuan,Shanxi,China,030001 [38]West China Hospital of Sichuan University,Cheng Du,Sichuan,China,610041 [39]Local Institution - 0025,Chengdu,Sichuan,China,610072 [40]Tianjin Medical University General Hospital,Tianjin,Tianjin,China,300052 [41]Tianjin People' s Hospital,Tianjin,Tianjin,China,300121 [42]Local Institution - 0049,Kunming,Yunnan,China,650034 [43]Sir Run Run Shaw Hospital of Zhejiang University School of Medicine,Hangzhou,Zhejiang,China,310016 [44]The First Affiliated Hospital Of Fujian Medical University,Fuzhou,China,350005 [45]Shanghai East Hospital,Shanghai,China,200120 [46]Changhua Christian Hospital,Changhua County,Changhua,Taiwan,50006 [47]Local Institution - 0060,Taipei City,Taipei,Taiwan,114 [48]Local Institution - 0058,New Taipei,Taiwan,235 [49]Local Institution - 0001,Taichung,Taiwan,40447 [50]Local Institution - 0059,Taichung,Taiwan,407 [51]Local Institution - 0056,Taipei,Taiwan,10002 [52]Local Institution - 0057,Taipei,Taiwan,11217 [53]Local Institution - 0055,Taoyuan,Taiwan,333

研究目的:
The purpose of this study is to evaluate the efficacy and safety of ozanimod compared with placebo in participants with ulcerative colitis (UC) in mainland China and Taiwan. The main study is composed of an induction period, maintenance period, safety follow-up, and participants meeting certain criteria will be given the opportunity to participate in an optional open label extension.

资源点击量:432 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)